Lonza PyroGene rFC assay

Tuesday, 11 January, 2011 | Supplied by: Capsugel Australia Pty Ltd

Lonza PyroGene rFC assay

The PyroGene recombinant Factor C assay (rFC) assay represents a reliable, sustainable alternative to LAL.

Factor C is the first component in the horseshoe crab clotting cascade activated by endotoxin. Recombinant Factor C (rFC) is activated by endotoxin binding, and the active enzyme then cleaves a synthetic substrate, resulting in the generation of a fluorogenic compound.

The reaction is run in a 96-well microplate and is measured at time zero and after a one-hour incubation in a fluorescent microplate reader using 380 nm excitation/440 nm emission wavelengths. The log net fluorescence is proportional to the log endotoxin concentration and is linear in the 0.01-10 EU/mL range.

Benefits include: endotoxin specific, recombinant technology eliminates false-positive glucan reactions; predictable, reliable lot-to-lot assay performance; sustainable resource - no animal utilisation; endpoint fluorescent assay, comparable to other quantitative LAL methods; and 510 (K) submissions have been approved by the FDA using PyroGene rFC Assay as a final release test.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)

The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...

Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms

The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...

ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation

ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd